Verrica Pharmaceuticals Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Verrica Pharmaceuticals Inc. (VRCA), sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Are VRCA insiders buying or selling?
Verrica Pharmaceuticals Inc. insiders reported 48 open-market buys ($80.6M) and 74 sells ($8.2M) across 122 Form 4 filings — a net buying position of $72.4M.
Source: SEC EDGAR Form 4
Key Statistics (as of Nov 26, 2025)
Insider sentiment
Net buyingNet insider flow of $72.4M in net buying.
Recent VRCA insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nov 26, 2025 | Noah L. Rosenberg | CMO | Purchase | 2.4K | $4.24 | $10.0K |
| Nov 26, 2025 | John J. Kirby | Interim CFO | Purchase | 3.5K | $4.24 | $15.0K |
| Nov 26, 2025 | David Zawitz | Chief Operating Officer | Purchase | 10.0K | $4.24 | $42.4K |
| Nov 26, 2025 | Jayson Rieger | CEO and President | Purchase | 94.3K | $4.24 | $400.1K |
| Nov 26, 2025 | Manning Paul B | Director, 10% Owner | Purchase | 4.1M | $4.24 | $17.5M |
| Mar 18, 2025 | Christopher G. Hayes | CHIEF LEGAL OFFICER | Sale | 4.3K | $0.65 | $2.8K |
| Nov 26, 2024 | Jayson Rieger | CEO and President | Purchase | 280.9K | $0.00 | $0 |
| Nov 26, 2024 | John A Stalfort III | Director | Purchase | 1.1M | $0.00 | $0 |
| Nov 26, 2024 | Manning Paul B | Director, 10% Owner | Purchase | 22.9M | $0.00 | $0 |
| Aug 28, 2024 | Christopher G. Hayes | CHIEF LEGAL OFFICER | Sale | 35.7K | $2.61 | $93.1K |
| Aug 28, 2024 | Gary Goldenberg | Chief Medical Officer | Sale | 13.5K | $2.61 | $35.2K |
| Aug 28, 2024 | Joe Bonaccorso | CHIEF COMMERCIAL OFFICER | Sale | 33.7K | $2.61 | $87.8K |
| Aug 28, 2024 | Terry Kohler | CHIEF FINANCIAL OFFICER | Sale | 29.7K | $2.61 | $77.5K |
| Aug 28, 2024 | Ted White | PRESIDENT AND CEO | Sale | 34.0K | $2.61 | $88.6K |
| Jul 23, 2024 | Ted White | PRESIDENT AND CEO | Sale | 32.6K | $7.06 | $230.3K |
| Jul 23, 2024 | Joe Bonaccorso | CHIEF COMMERCIAL OFFICER | Sale | 25.6K | $7.06 | $180.6K |
| Jul 23, 2024 | Gary Goldenberg | Chief Medical Officer | Sale | 18.5K | $7.06 | $130.7K |
| Jul 23, 2024 | Christopher G. Hayes | CHIEF LEGAL OFFICER | Sale | 21.7K | $7.06 | $153.5K |
| Dec 29, 2023 | Joseph Edelman | 10% Owner | Purchase | 321.6K | $7.17 | $2.3M |
| Dec 27, 2023 | Joseph Edelman | 10% Owner | Purchase | 504.7K | $6.45 | $3.3M |
| Dec 19, 2023 | Joseph Edelman | 10% Owner | Purchase | 1.2M | $5.63 | $6.9M |
| Nov 16, 2023 | Joe Bonaccorso | Chief Commercial Officer | Sale | 32.8K | $2.94 | $96.7K |
| Nov 16, 2023 | Gary Goldenberg | Chief Medical Officer | Sale | 8.9K | $2.94 | $26.1K |
| Nov 16, 2023 | Terry Kohler | Chief Financial Officer | Sale | 28.1K | $2.94 | $82.7K |
| Nov 16, 2023 | Ted White | President and CEO | Sale | 33.7K | $2.94 | $99.2K |
Showing the 25 most recent of 122 Form 4 filings for Verrica Pharmaceuticals Inc..
Most active VRCA insiders
- Matt Davidson55 filings
- Manning Paul B15 filings
- Ted White11 filings
- Christopher G. Hayes8 filings
- Gary Goldenberg5 filings
Ask anything about VRCA insider activity
Use Trabud's AI agent to query Verrica Pharmaceuticals Inc.'s Form 4 history in plain English — "Show me VRCA CEO purchases this year" or compare it against any other ticker.
Open the AI agentVRCA insider trading FAQ
Are Verrica Pharmaceuticals Inc. insiders buying or selling?
Across 122 SEC Form 4 filings, Verrica Pharmaceuticals Inc. (VRCA) insiders reported 48 open-market purchases totaling $80.6M and 74 sales totaling $8.2M. That is a net buying position of $72.4M.
How many insiders trade VRCA stock?
17 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Verrica Pharmaceuticals Inc.. The most recent filing was accepted on Nov 26, 2025.
Where does Trabud get VRCA insider trading data?
All VRCA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.